SCHEMBL15830751

SCHEMBL15830751

COc1ccc(F)c(OC=O)c1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
HTR2B P41595 2/20 0.36
ALDH1A1 P00352 5/20 0.35
GAA P10253 1/20 0.35
RAB9A P51151 4/20 0.35
MAPT P10636 4/20 0.35
HTT P42858 3/20 0.35
MAPK1 P28482 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MCL1 Q07820 2/20 0.35
KDM4E B2RXH2 1/20 0.35
S1PR4 O95977 1/20 0.35
HSP90AA1 P07900 1/20 0.35
G6PD P11413 1/20 0.35
S1PR1 P21453 1/20 0.35
OPRK1 P41145 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30013891 0.82 FLT1 (0.35) HTR2AHTR2CHTR2BALDH1A1MAPT
SCHEMBL23723813 0.82 FLT1 (0.35) HTR2AHTR2CHTR2BALDH1A1MAPT
SCHEMBL17479900 0.76 MEP1B (0.39) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL16263963 0.76 MAPT (0.40) ALDH1A1GAARAB9AMAPTHTT
SCHEMBL2253680 0.75 ERN1 (0.42) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL12804213 0.73 HTR2A (0.47) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL1358908 0.71 ERN1 (0.42) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL7939401 0.71 HTR2A (0.42) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL27440101 0.71 HTR2C (0.30) HTR2AHTR2CHTR2B
SCHEMBL15334770 0.70 HTR2A (0.41) HTR2AHTR2CHTR2BALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233368-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2017-08-17 US disclosed
US-20150175572-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2015-06-25 US disclosed
US-9040515-B2 Aryl and heteroaryl fused lactams PFIZER INC. (US) 2015-05-26 US disclosed
US-20140179667-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179667-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 HTR2A 3810/4885HTR2C 3482/4885HTR2B 3560/4885
US-20170233368-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 HTR2A 3810/4885HTR2C 3482/4885HTR2B 3560/4885
US-20150175572-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 HTR2A 3810/4885HTR2C 3482/4885HTR2B 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.